Skip to main content
Abstract
Originally Published 1 March 1994
Free Access

Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.

First page of PDF

Formats available

You can view the full content in the following formats:

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Circulation
Circulation
Pages: 1449 - 1468
PubMed: 8124829

History

Published online: 1 March 1994
Published in print: March 1994

Permissions

Request permissions for this article.

Authors

Affiliations

J Hirsh
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
V Fuster
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Bioengineered heparin: Advances in production technology, Biotechnology Advances, 77, (108456), (2024).https://doi.org/10.1016/j.biotechadv.2024.108456
    Crossref
  2. Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice, Seminars in Thrombosis and Hemostasis, 50, 08, (1153-1162), (2024).https://doi.org/10.1055/s-0044-1786990
    Crossref
  3. Sodium bicarbonate as a local adjunctive agent for limiting platelet activation, aggregation, and adhesion within cardiovascular therapeutic devices, Journal of Thrombosis and Thrombolysis, 56, 3, (398-410), (2023).https://doi.org/10.1007/s11239-023-02852-4
    Crossref
  4. Therapeutic Agent-Loaded Fibrous Scaffolds for Biomedical Applications, Pharmaceutics, 15, 5, (1522), (2023).https://doi.org/10.3390/pharmaceutics15051522
    Crossref
  5. A Case of Antiphospholipid Syndrome Underwent Cardiac Surgery Performed Using Coagulation Management by Measuring Heparin Concentration during Extracorporeal Circulation体外循環中ヘパリン濃度測定による抗凝固管理下で開心術を施行した抗リン脂質抗体症候群合併の1例, Japanese Journal of Cardiovascular Surgery, 52, 1, (9-13), (2023).https://doi.org/10.4326/jjcvs.52.9
    Crossref
  6. Formulation and testing of a slow-release antimicrobial paint: a case study of antifungi and antialgae activity for interior and exterior applications, Journal of Coatings Technology and Research, (2022).https://doi.org/10.1007/s11998-022-00691-1
    Crossref
  7. Polydopamine-heparin complex reinforced antithrombotic and antimicrobial activities of heparinized hydrogels for biomedical applications, Composites Part A: Applied Science and Manufacturing, 157, (106908), (2022).https://doi.org/10.1016/j.compositesa.2022.106908
    Crossref
  8. Size‐ and charge‐dependent modulation of the lytic susceptibility and mechanical stability of fibrin‐histone clots by heparin and polyphosphate variants, Journal of Thrombosis and Haemostasis, 19, 5, (1307-1318), (2021).https://doi.org/10.1111/jth.15258
    Crossref
  9. Development and Evaluation of a Heparin Gel for Transdermal Delivery Via laser-generated Micropores, Therapeutic Delivery, 12, 2, (133-144), (2021).https://doi.org/10.4155/tde-2020-0024
    Crossref
  10. Repurposing Heparin as Antimalarial: Evaluation of Multiple Modifications Toward In Vivo Application, Pharmaceutics, 12, 9, (825), (2020).https://doi.org/10.3390/pharmaceutics12090825
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
Circulation
  • Vol. 89
  • No. 3

Purchase access to this journal for 24 hours

Circulation
  • Vol. 89
  • No. 3
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Figures

Tables

Media

Share

Share

Share article link

Share

Comment Response